Tara Bancroft
Stock Analyst at TD Cowen
(2.83)
# 1,703
Out of 4,854 analysts
8
Total ratings
66.67%
Success rate
25.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $40.16 | +24.50% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $54.72 | +18.79% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $8.68 | +26.73% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.59 | +528.93% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $56.85 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.66 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $40.16
Upside: +24.50%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $54.72
Upside: +18.79%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $8.68
Upside: +26.73%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.59
Upside: +528.93%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $56.85
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.66
Upside: -